Rhumbline Advisers Portfolio Holdings

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

Rhumbline Advisers has filed its 13F form on May 29, 2025 for Q1 2025 where it was disclosed a total value porftolio of $104 Billion distributed in 4182 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $6.35B, Microsoft Corp with a value of $5.37B, Nvidia Corp with a value of $4.93B, Amazon Com Inc with a value of $3.35B, and Meta Platforms, Inc. with a value of $2.38B.

Examining the 13F form we can see an increase of $23.5M in the current position value, from $104B to 104B.

Rhumbline Advisers is based out at Boston, MA

Below you can find more details about Rhumbline Advisers portfolio as well as his latest detailed transactions.

Portfolio value $104 Billion
Technology: $29.7 Billion
Financial Services: $15.1 Billion
Healthcare: $11.4 Billion
Consumer Cyclical: $11.4 Billion
Industrials: $9.61 Billion
Communication Services: $8.97 Billion
Consumer Defensive: $6 Billion
Energy: $3.88 Billion
Other: $8.18 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Team Inc Com
-
$0 0.0% of portfolio
-
Q3 2024 New
$2.1B
$12,000 0.0% of portfolio
2,010
Q4 2024 Reduced 19.92%
$7.54B
$203,000 0.0% of portfolio
6,242
Q4 2024 Added 115.62%
$3.15B
$53,000 0.0% of portfolio
11,996
Q3 2024 Added 53.58%
Techtarget Inc Com
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 1.14%
$19.4B
$0 0.0% of portfolio
-
Q4 2024 Added 4.69%
$20.2B
$41,000 0.0% of portfolio
1,134
Q4 2024 Reduced 16.49%
$3.65B
$2.2 Million 0.0% of portfolio
30,707
Q4 2024 Reduced 7.27%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Teekay Corp LTD
-
$0 0.0% of portfolio
-
Q4 2024 Added 4.41%
Teekay Tankers LTD Cl A
-
$0 0.0% of portfolio
-
Q4 2024 Added 4.26%
$501M
$514,000 0.0% of portfolio
32,430
Q4 2024 Added 5.84%
$1.37B
$2.16 Million 0.0% of portfolio
271,434
Q4 2024 Added 3.68%
$10B
$107,000 0.0% of portfolio
32,302
Q4 2024 Added 10.65%
$18B
$36,000 0.0% of portfolio
4,233
Q4 2024 Reduced 77.16%
$30.6B
$467,000 0.0% of portfolio
100,249
Q4 2024 Reduced 5.81%
$22.3B
$400,000 0.0% of portfolio
27,973
Q4 2024 Added 5.14%
$5.9B
$233,000 0.0% of portfolio
4,642
Q4 2024 Added 0.65%
$0
$151,000 0.0% of portfolio
20,936
Q4 2024 Added 7.05%
Telix Pharmaceuticals LTD
-
$0 0.0% of portfolio
-
Q1 2025 New
Telomir Pharmaceuticals
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 26.7%
$198M
$189,000 0.0% of portfolio
79,692
Q4 2024 Added 0.74%
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 5.59%
$23.6B
$1.6 Million 0.0% of portfolio
111,354
Q4 2024 Added 2.06%
$5.66B
$74,000 0.0% of portfolio
966
Q4 2024 Added 2.9%
Tempus Ai Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$22.3B
$314,000 0.0% of portfolio
8,049
Q4 2024 Added 4.51%
$35.2M
$39,000 0.0% of portfolio
69,193
Q4 2024 Added 16.61%
$648B
$2.2 Million 0.0% of portfolio
34,493
Q4 2024 Added 103.1%
$36.2B
$1.59 Million 0.0% of portfolio
110,641
Q4 2024 Added 4.85%
$1.5B
$4.49 Million 0.0% of portfolio
56,312
Q4 2024 Added 1.05%
$627M
$999,000 0.0% of portfolio
366,217
Q4 2024 Reduced 5.25%
$20.4B
$3,000 0.0% of portfolio
146
Q2 2024 Reduced 84.65%
$6.21B
$42,000 0.0% of portfolio
1,354
Q4 2024 Added 7.53%
$216M
$266,000 0.0% of portfolio
96,659
Q4 2024 Added 1.28%
$12B
$210,000 0.0% of portfolio
11,215
Q4 2024 Added 0.84%
$43.3B
$525,000 0.0% of portfolio
40,653
Q4 2024 Added 17.58%
$450M
$727,000 0.0% of portfolio
216,479
Q4 2024 Reduced 4.09%
Tetraphase Pharmaceuticals Cvr
-
$0 0.0% of portfolio
-
Q2 2023 New
$18.1B
$4.32 Million 0.0% of portfolio
281,062
Q4 2024 Reduced 0.76%
Tevogen Bio Hldgs Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 20.89%
$3.65B
$621,000 0.0% of portfolio
50,193
Q4 2024 Added 0.9%
Tgs Nopec Geophys Adr
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 56.65%
$60.4B
$579,000 0.0% of portfolio
10,865
Q4 2024 Reduced 9.06%
The A2 Milk CO Ltd Unsp Adr
-
$0 0.0% of portfolio
-
Q3 2023 Added 42.04%
$168M
$207,000 0.0% of portfolio
16,627
Q4 2024 Reduced 4.97%
$775M
$609,000 0.0% of portfolio
150,008
Q4 2024 Reduced 17.12%
$614M
$784,000 0.0% of portfolio
145,543
Q4 2024 Reduced 1.24%
The9 LTD Adr
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 7.12%

Summary

  • Portfolio
  • No. of Stocks 4,182
  • Current Value $104 Billion
  • Prior Value $104 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 29, 2025
  • Form Type 13F-HR/A
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email